Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 10;103(19):e38022.
doi: 10.1097/MD.0000000000038022.

Efficacy of human prothrombin complex concentrate in the treatment of warfarin overdose in patients receiving warfarin for mechanical heart valve replacement

Hasan Uncu  1 , Tolga Onur Badak  1 , Haci Ali Ucak  1 , Ferid Cereb  1 , Ahmet Cakallioglu  2
Affiliations

Efficacy of human prothrombin complex concentrate in the treatment of warfarin overdose in patients receiving warfarin for mechanical heart valve replacement

Hasan Uncu et al. Medicine (Baltimore). .

Abstract

Warfarin, a widely utilized anticoagulant, is paramount for preventing thromboembolic events in patients with mechanical heart valve replacements. However, its narrow therapeutic index can lead to over-anticoagulation and overdose, resulting in serious health risks. This study examines the efficacy of human prothrombin complex concentrate (PCC) in managing warfarin overdose, in comparison with traditional treatments. A retrospective analysis was conducted on 162 adults who presented with warfarin overdose (INR > 5.0) at a tertiary care hospital between 2016 and 2020. Participants were divided into 2 groups-those treated with PCC (n = 57) and those treated with conventional methods (n = 105), including vitamin K and fresh frozen plasma. The primary outcome was the rate of reaching the target (International Normalized Ratio) INR within 24 hours. Secondary outcomes included transfusion requirements, thromboembolic events, adverse reactions, 30-day mortality, and length of hospital stay. PCC demonstrated significant efficacy, with 89.5% of patients achieving the target INR within 24 hours, compared to 64.8% in the control group (P < .05). The PCC group also had reduced transfusion requirements and a shorter average hospital stay. There was no significant difference in thromboembolic events or adverse reactions between the 2 groups, and the reduced 30-day mortality in the PCC group was not statistically significant. Human prothrombin complex concentrate is associated with rapid reaching the target INR, decreased transfusion needs, and shortened hospitalization, making it a promising option for warfarin overdose management. While the results are encouraging, larger, multicenter, randomized controlled trials are necessary to further validate these findings and optimize PCC administration protocols.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Similar articles

See all similar articles

References

    1. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167:1414–9. - PubMed
    1. Altiok E, Marx N. Orale Antikoagulation. Deutsches Arzteblatt International. 2018;115:776–83. - PMC - PubMed
    1. Ueyama H, Kuno T, Ando T, et al. . Meta-analysis comparing direct oral anticoagulants versus Vitamin K antagonists after transcatheter aortic valve implantation. Am J Cardiol. 2020;125:1102–7. - PubMed
    1. Budnitz DS, LoveGrove MC, Shehab N, et al. . Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–12. - PubMed
    1. Patel FA, Chauhan M, Rai S, et al. . Warfarin toxicity. Int J Pharm Sci Rev Res. 2022;77:34–7.

MeSH terms